New hope for kidney revival for transplant

July 14, 2020

New research has demonstrated that kidneys can be revived prior to transplantation by delivering a cell therapy directly to the organ.

A team led by Newcastle University researcher, Dr Emily Thompson, is the first to discover that a new technique called Normothermic Machine Perfusion - when combined with stem cells - can be used to improve the function of 'marginal' kidneys, organs that are at risk of not working as well.

By treating kidneys with a type of stem cell called MultiStem the organs demonstrated a number of responses associated with better function caused by the release of anti-inflammatory molecules, improving blood flow to damaged cells and increasing urine production.

The research is published in the American Journal of Transplantation and Dr Thompson, from the Translational and Clinical Research institute, Newcastle University, UK and transplant surgery registrar at Newcastle Hospitals NHS Foundation Trust, led the research project. She is funded by Kidney Research UK and by the NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation.

"By improving the quality of donor kidneys and increasing the number available, we hope to be able to reduce the waiting time and improve the health outcomes for patients," said Dr Thompson.

Shortage of kidneys to transplant

Kidney transplantation is the best treatment for patients with kidney failure, however, on average, patients wait three years for an organ to become available.

Many kidneys offered for donation are classified as marginal and this can often lead to post-transplant problems, increasing the chances of a patient requiring a second organ.

Dr Thompson said: "It was exciting to see the results of the research as it could offer a new way to make more kidneys suitable for transplant. It could offer hope to more people on dialysis and shorten the waiting list.

"This work has completely changed our thinking as it shows that we may be able to pre-treat the kidney directly, instead of treating the whole patient before or after transplantation. This opens up exciting opportunities to explore other therapies, such as gene therapy or other stem cells, and we are moving our research forward and looking at a lot of other drugs and therapies.

"Currently these tests are done in the lab but if they transfer to the patient setting, as we hope they will, those who receive a transplant may receive better quality kidneys that last a lifetime."

"This exciting research shows that stem cell treatment could improve the quality of donor kidneys," said Dr Maria Tennant, Head of Communications at Kidney Research UK.

"Right now, there are not enough kidney transplants available for everyone who needs one, and a transplant doesn't last for life. We hope this treatment ultimately means more kidneys become fit for transplant and are able to last much longer."

Reviving organs

Normothermic Machine Perfusion, a recently-established method for organ preservation - optimises metabolism primarily for storage and transportation and pumps oxygenated blood through the organ at body temperature, keeping the kidney working after it has been removed from the donor. This research focussed on whether the technique can also be used to deliver treatments to improve kidney function.

The benefit of this technique is that treatments can be delivered directly to the kidney. It is performed while the kidney is outside of the body so there are fewer concerns about side effects in a patient.

In the research, Dr Thompson treated kidneys with an adult stem cell product candidate called MultiStem™ which is being developed by Athersys,Inc. based in Cleveland, Ohio. The treated kidneys showed a number of responses associated with better function caused by the release of anti-inflammatory molecules (cytokines and growth factors specifically reduction of IL-1beta, an increase in IL-10 and IDO activity) which improved blood flow to damaged cells leading to increased urine production.

Dr Thompson has already been recognised for this work receiving the Medawar medal from the British Transplantation Society and the Da Vinci award from the European Society of Transplantation.

The next step is to find out if the improvements seen on the machine result in better transplants. Dr Thompson will be progressing the work with further research and testing and it is hoped this innovation will progress to human clinical trials within a few years.
REFERENCE: Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation, Emily R. Thompson et al. American Journal of Transplantation.

Newcastle University

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to